Union Of India & Anr vs M/S Swiss Garnier Life Sciences & Ors

The Supreme Court upheld the Delhi High Court's decision affirming the order that set aside the price fixation Notifications for 'Doxofylline formulations' issued under the Drugs (Prices Control) Order, 1995 (DPCO, 1995). The Court ruled that 'Doxofylline' does not qualify as a bulk drug under para 2(a) of the DPCO, 1995, thereby establishing that the price control measures could not be applied to it. Consequently, the appeals by the Union of India were dismissed, maintaining the High Court's stance on the matter.